Correlation Between Vir Biotechnology and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vir Biotechnology and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vir Biotechnology and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vir Biotechnology and Candel Therapeutics, you can compare the effects of market volatilities on Vir Biotechnology and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vir Biotechnology with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vir Biotechnology and Candel Therapeutics.
Diversification Opportunities for Vir Biotechnology and Candel Therapeutics
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vir and Candel is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Vir Biotechnology and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Vir Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vir Biotechnology are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Vir Biotechnology i.e., Vir Biotechnology and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Vir Biotechnology and Candel Therapeutics
Considering the 90-day investment horizon Vir Biotechnology is expected to generate 0.81 times more return on investment than Candel Therapeutics. However, Vir Biotechnology is 1.23 times less risky than Candel Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Candel Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 937.00 in Vir Biotechnology on September 4, 2024 and sell it today you would lose (17.00) from holding Vir Biotechnology or give up 1.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vir Biotechnology vs. Candel Therapeutics
Performance |
| Timeline |
| Vir Biotechnology |
| Candel Therapeutics |
Vir Biotechnology and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vir Biotechnology and Candel Therapeutics
The main advantage of trading using opposite Vir Biotechnology and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vir Biotechnology position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Vir Biotechnology vs. Candel Therapeutics | Vir Biotechnology vs. Cingulate Warrants | Vir Biotechnology vs. Unicycive Therapeutics | Vir Biotechnology vs. Cardio Diagnostics Holdings |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |